A prospective, randomised, open label trial on the effect of metformin on in-vitro fertilisation outcome in women with polycystic ovary syndrome
Phase 3
- Conditions
- InfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisationPolycystic ovary syndromeMetabolic and Endocrine - Other metabolic disorders
- Registration Number
- ACTRN12609000510246
- Lead Sponsor
- Fertility Society of Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 124
Inclusion Criteria
Polycystic ovary syndrome(PCOS)
Infertility
Both ovaries present
Informed Consent to in-vitro fertilisation treatment
Age 20-38years inclusive
Use of an Antagonist cycle
Exclusion Criteria
Contraindication to metformin
Metformin use in previous month
Previous participation in the trial
Oocyte donor
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method